Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
126.8 USD | +4.34% |
|
+8.87% | +27.06% |
15/07 | Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing | MT |
12/07 | China approves CSPC Pharma's RSV vaccine for clinical trials | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.06% | 4.66TCr | |
+45.38% | 4.17TCr | |
+0.03% | 4.12TCr | |
+32.46% | 3.24TCr | |
+20.83% | 2.82TCr | |
-6.35% | 2.81TCr | |
+48.96% | 1.45TCr | |
+47.91% | 1.37TCr | |
+3.16% | 1.22TCr | |
-4.19% | 1.11TCr |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna : U.K. regulators authorize use of Moderna vaccine, the third COVID-19 vaccine to be licensed for use in the country